Description

RGD is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)–Cancer-programmed cell death–C12H22N6O6—Cancer Sci. 2020 May 24;111(8):2803-2813. |Int J Biol Macromol. 2023 Aug 31;126499.|Mater Sci Forum. 2019, 955: 68-73.|Chem Eng J. 5 February 2022, 135088.|Colloid Polym Sci. 2023 Feb 27.-[1]Hersel U, et al. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003 Nov;24(24):4385-415.–99896-85-2–346.34–98.37–O=C(O)C[C@@H](C(O)=O)NC(CNC([C@H](CCCNC(N)=N)N)=O)=O–Cancer–DMSO : 1.94 mg/mL (ultrasonic;adjust pH to 3 with HCl)|H2O : 10 mg/mL (ultrasonic)–Integrin—-Cytoskeleton–Peptides